| scholarly article | Q13442814 |
| retracted paper | Q45182324 |
| P50 | author | Piero Anversa | Q3903152 |
| P2093 | author name string | A. Leri | |
| J. Kajstura | |||
| P2860 | cites work | Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages | Q24310167 |
| Evidence for cardiomyocyte renewal in humans | Q24594522 | ||
| Molecular basis of cardiac performance. Plasticity of the myocardium generated through protein isoform switches | Q24621025 | ||
| Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand | Q24644662 | ||
| In vivo fate analysis reveals the multipotent and self-renewal capacities of Sox2+ neural stem cells in the adult hippocampus | Q24683755 | ||
| Bone marrow cells regenerate infarcted myocardium | Q28210640 | ||
| Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury | Q28252995 | ||
| Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification | Q28275356 | ||
| A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease | Q29028464 | ||
| Regulation of cardiac hypertrophy by intracellular signalling pathways | Q29615166 | ||
| Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo | Q29619355 | ||
| The orderly allocation of mesodermal cells to the extraembryonic structures and the anteroposterior axis during gastrulation of the mouse embryo | Q60982889 | ||
| Identification of Myocardial and Vascular Precursor Cells in Human and Mouse Epicardium | Q61824978 | ||
| Mechanisms of contraction of the normal and failing heart | Q69824447 | ||
| Mechanisms of contraction of the normal and failing heart | Q69828419 | ||
| Bone marrow infarction in sickle cell anemia | Q71250069 | ||
| Apoptosis in myocytes in end-stage heart failure | Q71554187 | ||
| Purification and characterization of heterogeneous pluripotent hematopoietic stem cell populations expressing high levels of c-kit receptor | Q72088953 | ||
| Myocyte cellular hyperplasia and myocyte cellular hypertrophy contribute to chronic ventricular remodeling in coronary artery narrowing-induced cardiomyopathy in rats | Q72269886 | ||
| Gastrointestinal involvement in leukocytoclastic vasculitis and polyarteritis nodosa | Q72440480 | ||
| Human hepatic infarction: histopathological and postmortem angiological studies | Q72652162 | ||
| Apoptosis in the failing human heart | Q73215232 | ||
| The way to a human's heart is through the stomach: visceral endoderm-like cells drive human embryonic stem cells to a cardiac fate | Q73469345 | ||
| Polyangitis overlap syndrome: a fatal case combined with adult Henoch-Schönlein purpura and polyarteritis nodosa | Q73744029 | ||
| Chimerism of the Transplanted Heart | Q77452324 | ||
| Heart failure from the point of view of quantitative anatomy∗ | Q78826681 | ||
| CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells | Q79317344 | ||
| Tissue-specific adult stem cells in the human lung | Q84911178 | ||
| Human cardiac stem cells: the heart of a truth | Q85055541 | ||
| Adult cardiac stem cells are multipotent and support myocardial regeneration | Q29620122 | ||
| Imaging survival and function of transplanted cardiac resident stem cells | Q30494736 | ||
| BMP signals promote proepicardial protrusion necessary for recruitment of coronary vessel and epicardial progenitors to the heart | Q30496194 | ||
| Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo | Q33270812 | ||
| Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis | Q33285990 | ||
| Bone marrow cells adopt the cardiomyogenic fate in vivo | Q33304156 | ||
| Effects of intracoronary autologous bone marrow cells on left ventricular function in acute myocardial infarction: a systematic review and meta-analysis for randomized controlled trials | Q33349711 | ||
| Role of the ATP-binding cassette transporter Abcg2 in the phenotype and function of cardiac side population cells | Q33369009 | ||
| Isolation of Resident Cardiac Progenitor Cells by Hoechst 33342 Staining | Q33648100 | ||
| Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction | Q33777861 | ||
| Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure | Q33853869 | ||
| Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function | Q33863225 | ||
| Cardiomyogenic potential of C-kit(+)-expressing cells derived from neonatal and adult mouse hearts | Q33887672 | ||
| Evidence that human cardiac myocytes divide after myocardial infarction | Q33950386 | ||
| Cardiovascular Control Mechanisms in the Conscious State | Q34048598 | ||
| Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair | Q34103630 | ||
| Cardiomyogenesis in the adult human heart | Q34330219 | ||
| p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes | Q34415888 | ||
| Cardiac neural crest cells contribute to the dormant multipotent stem cell in the mammalian heart | Q34454071 | ||
| Control of cardiac growth by histone acetylation/deacetylation | Q34482206 | ||
| Myocyte renewal and ventricular remodelling | Q34503420 | ||
| Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages | Q34579177 | ||
| Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury | Q34657173 | ||
| Stem cell niches in the adult mouse heart | Q34657903 | ||
| Cardiac plasticity | Q34764732 | ||
| Functionally competent cardiac stem cells can be isolated from endomyocardial biopsies of patients with advanced cardiomyopathies | Q34781505 | ||
| Cardiomyocyte renewal. | Q34990218 | ||
| Evidence for human lung stem cells | Q35399248 | ||
| Electrical Remodeling in Cardiac Hypertrophy | Q35575175 | ||
| Hyperplasia of myocyte nuclei in long-term cardiac hypertrophy in rats | Q35584179 | ||
| Regeneration of heart muscle tissue: quantification of chimeric cardiomyocytes and endothelial cells following transplantation | Q35619055 | ||
| Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy | Q35918432 | ||
| Human cardiac stem cells | Q35956924 | ||
| Bone marrow embolism in sickle cell disease: a review | Q36105418 | ||
| The post-natal heart contains a myocardial stem cell population. | Q45855585 | ||
| Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction | Q46259595 | ||
| Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development | Q46350581 | ||
| Development biology. Turnover after the fallout | Q47272910 | ||
| Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. | Q48414650 | ||
| Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair | Q53540644 | ||
| Acute renal infarction | Q53593244 | ||
| Influence of chronic captopril therapy on the infarcted left ventricle of the rat. | Q54447887 | ||
| Myocardial infarction induces embryonic reprogramming of epicardial c-kit(+) cells: role of the pericardial fluid. | Q54705281 | ||
| Cardiac Stem Cells Possess Growth Factor-Receptor Systems That After Activation Regenerate the Infarcted Myocardium, Improving Ventricular Function and Long-Term Survival | Q57395179 | ||
| Lost in translation | Q59057872 | ||
| Cardiac stem cells and mechanisms of myocardial regeneration | Q36267790 | ||
| Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction | Q36349782 | ||
| Controversies in ventricular remodelling | Q36380191 | ||
| Cardiac regeneration: repopulating the heart | Q36387864 | ||
| Formation of large coronary arteries by cardiac progenitor cells | Q36446471 | ||
| Getting to the Heart of Myocardial Stem Cells and Cell Therapy | Q36540656 | ||
| Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues | Q36580764 | ||
| The fuzzy logic of physiological cardiac hypertrophy | Q36772114 | ||
| Origins and fates of cardiovascular progenitor cells | Q36828639 | ||
| Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. | Q36952843 | ||
| Lives of a heart cell: tracing the origins of cardiac progenitors | Q37132482 | ||
| Aging and disease as modifiers of efficacy of cell therapy | Q37183949 | ||
| Does contractile Ca2+ control calcineurin-NFAT signaling and pathological hypertrophy in cardiac myocytes? | Q37199523 | ||
| Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice | Q37286681 | ||
| Identification of a coronary vascular progenitor cell in the human heart | Q37354199 | ||
| Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function | Q37355668 | ||
| Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo | Q37375494 | ||
| Clonality of mouse and human cardiomyogenesis in vivo | Q37385968 | ||
| Molecular imaging of cell death | Q37441796 | ||
| Regeneration next: toward heart stem cell therapeutics | Q37606681 | ||
| Pregenerative medicine: developmental paradigms in the biology of cardiovascular regeneration | Q37668953 | ||
| Origin of cardiac progenitor cells in the developing and postnatal heart | Q37766810 | ||
| Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications | Q37850831 | ||
| Effects of hypertrophy on the coronary circulation | Q39485898 | ||
| Left ventricular hypertrophy: A cytometric study on 42 human hearts | Q39828856 | ||
| Mechanisms of contraction of the normal and failing heart | Q39883441 | ||
| Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia | Q40608302 | ||
| A myocardial lineage derives from Tbx18 epicardial cells | Q41213731 | ||
| Gender differences and aging: effects on the human heart | Q41668567 | ||
| Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction | Q42644713 | ||
| Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin. | Q42945812 | ||
| Myocyte turnover in the aging human heart | Q43415029 | ||
| Lentivector-mediated clonal tracking reveals intrinsic heterogeneity in the human hematopoietic stem cell compartment and culture-induced stem cell impairment | Q43487715 | ||
| Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial | Q43930568 | ||
| Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes | Q44710997 | ||
| CD117-positive cells in adult human heart are localized in the subepicardium, and their activation is associated with laminin-1 and alpha6 integrin expression | Q44775190 | ||
| Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice | Q45171605 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | paradigm shift | Q689971 |
| pathophysiology | Q1135939 | ||
| P304 | page(s) | 941-61 | |
| P577 | publication date | 2011-09-30 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology | |
| P478 | volume | 109 |
| Q38039312 | 'Shovel-Ready' applications of stem cell advances for pediatric heart disease |
| Q48465977 | 3D printed complex tissue construct using stem cell-laden decellularized extracellular matrix bioinks for cardiac repair |
| Q42007631 | A Novel Class of Human Cardiac Stem Cells |
| Q38308664 | A journey from basic stem cell discovery to clinical application: the case of adventitial progenitor cells |
| Q84112015 | A thermosensitive hydrogel capable of releasing bFGF for enhanced differentiation of mesenchymal stem cell into cardiomyocyte-like cells under ischemic conditions |
| Q30574363 | ATP-binding cassette G-subfamily transporter 2 regulates cell cycle progression and asymmetric division in mouse cardiac side population progenitor cells |
| Q36065239 | Accumulation of Mitochondrial DNA Mutations Disrupts Cardiac Progenitor Cell Function and Reduces Survival. |
| Q35673689 | Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI) |
| Q30564050 | Age-associated defects in EphA2 signaling impair the migration of human cardiac progenitor cells |
| Q35827637 | Aging Kit Mutant Mice Develop Cardiomyopathy |
| Q57184098 | An oxygen release system to augment cardiac progenitor cell survival and differentiation under hypoxic condition |
| Q30420229 | Angiogenesis effect of therapeutic ultrasound on ischemic hind limb in mice |
| Q38032602 | Angiogenesis in the infarcted myocardium |
| Q38431346 | Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms. |
| Q38025802 | Anti-HLA antibodies in regenerative medicine stem cell therapy |
| Q48623367 | Antiarrhythmic effect of growth factor-supplemented cardiac progenitor cells in chronic infarcted heart. |
| Q57396465 | Are Resident c-Kit + Cardiac Stem Cells Really All That Are Needed to Mend a Broken Heart? |
| Q39514108 | At a crossroad: cell therapy for cardiac repair |
| Q36449881 | Biochemical Markers of Aging for Longitudinal Studies in Humans |
| Q36793257 | Bioenergetic and functional consequences of cellular therapy: activation of endogenous cardiovascular progenitor cells |
| Q42376309 | Bmi1 and BRG1 drive myocardial repair by regulating cardiac stem cell function in acute rheumatic heart disease |
| Q42558612 | Bone Marrow Therapy for Myocardial Infarction |
| Q58767602 | Bradykinin-mediated Ca signalling regulates cell growth and mobility in human cardiac c-Kit progenitor cells |
| Q37692583 | CENP-A is essential for cardiac progenitor cell proliferation |
| Q38835689 | Calcific Aortic Valve Disease: Part 2-Morphomechanical Abnormalities, Gene Reexpression, and Gender Effects on Ventricular Hypertrophy and Its Reversibility |
| Q50577371 | Cardiac Repair With a Novel Population of Mesenchymal Stem Cells Resident in the Human Heart |
| Q38067273 | Cardiac Stem Cells and their Roles in Myocardial Infarction |
| Q35695769 | Cardiac aging - Getting to the stem of the problem. |
| Q41241273 | Cardiac cell proliferation is not necessary for exercise-induced cardiac growth but required for its protection against ischaemia/reperfusion injury |
| Q38336874 | Cardiac regeneration in children |
| Q83451816 | Cardiac regeneration: messages from CADUCEUS |
| Q34643788 | Cardiac regenerative capacity and mechanisms |
| Q26862552 | Cardiac side population cells: moving toward the center stage in cardiac regeneration |
| Q34621825 | Cardiac stem cell niches |
| Q36603788 | Cardiac stem cells: A promising treatment option for heart failure |
| Q26825051 | Cardiac stem cells: biology and clinical applications |
| Q57046917 | Cardiomyocyte Renewal in Humans |
| Q35798731 | Cardiomyogenesis in the developing heart is regulated by c-kit-positive cardiac stem cells |
| Q27001159 | Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions |
| Q36176132 | Cell-based therapy for prevention and reversal of myocardial remodeling |
| Q38027920 | Cellular cardiomyoplasty: current state of the field. |
| Q38669503 | Chasing c-Kit through the heart: Taking a broader view |
| Q37627155 | Chronic heart failure: opportunities for a bridge between China and the United States |
| Q87056671 | Circulation Research Thematic Synopsis: stem cells & cardiac progenitor cells |
| Q51062992 | Comparison of cardiac stem cell sheets detached by Versene solution and from thermoresponsive dishes reveals similar properties of constructs. |
| Q39265109 | Concurrent Isolation of 3 Distinct Cardiac Stem Cell Populations From a Single Human Heart Biopsy |
| Q27004753 | Current Stem Cell Delivery Methods for Myocardial Repair |
| Q38280311 | Developmental origins and lineage descendants of endogenous adult cardiac progenitor cells. |
| Q46779139 | Differentiation ability of multipotent hematopoietic stem/progenitor cells detected by a porcine specific anti-CD117 monoclonal antibody. |
| Q30539951 | Direct visualization of cell division using high-resolution imaging of M-phase of the cell cycle |
| Q41166628 | Downregulation of miR-133 via MAPK/ERK signaling pathway involved in nicotine-induced cardiomyocyte apoptosis |
| Q53382563 | Effect of therapeutic ultrasound on brain angiogenesis following intracerebral hemorrhage in rats |
| Q46222743 | Effects of nitric oxide on cell proliferation: novel insights |
| Q37199307 | Endocrine protection of ischemic myocardium by FGF21 from the liver and adipose tissue |
| Q98245653 | Enhancing myocardial repair with CardioClusters |
| Q85638880 | Enlightened stem cells in the heart: more efficient and safer reporter gene imaging |
| Q34224125 | Epigenetic modifications of stem cells: a paradigm for the control of cardiac progenitor cells. |
| Q34046358 | Evidence for Mechanisms Underlying the Functional Benefits of a Myocardial Matrix Hydrogel for Post-MI Treatment |
| Q38304096 | Exosome and its roles in cardiovascular diseases |
| Q38179329 | Exosomes and cardiac repair after myocardial infarction |
| Q90735653 | Expression of Concern |
| Q95387984 | Expression of Concern |
| Q85662889 | Extracorporeal low-energy shock-wave therapy exerts anti-inflammatory effects in a rat model of acute myocardial infarction |
| Q27309113 | Fetal Myocardium in the Kidney Capsule: An In Vivo Model of Repopulation of Myocytes by Bone Marrow Cells |
| Q37274406 | Fibronectin is essential for reparative cardiac progenitor cell response after myocardial infarction |
| Q38124390 | From cell phenotype to epigenetic mechanisms: new insights into regenerating myocardium |
| Q38037177 | From ontogenesis to regeneration: learning how to instruct adult cardiac progenitor cells. |
| Q30575719 | Functional consequences of human induced pluripotent stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling. |
| Q38129528 | Future treatment strategies in ST-segment elevation myocardial infarction |
| Q47761187 | GLP-1 Receptor Activation Inhibits Palmitate-Induced Apoptosis via Ceramide in Human Cardiac Progenitor Cells |
| Q37971241 | Gap junctions, stem cells, and cell therapy: Rhythmic/arrhythmic implications |
| Q38025012 | Gene and cytokine therapy for heart failure: molecular mechanisms in the improvement of cardiac function |
| Q89506727 | Genetic Lineage Tracing of Sca-1+ Cells Reveals Endothelial but Not Myogenic Contribution to the Murine Heart |
| Q38745509 | Harnessing the secretome of cardiac stem cells as therapy for ischemic heart disease |
| Q38006736 | Heart repair: from natural mechanisms of cardiomyocyte production to the design of new cardiac therapies |
| Q41927822 | Human Parvovirus B19 (B19V) Up-regulates CXCR4 Surface Expression of Circulating Angiogenic Cells: Implications for Cardiac Ischemia in B19V Cardiomyopathy. |
| Q38408964 | Human Umbilical Cord Mesenchymal Stromal Cell Transplantation in Myocardial Ischemia (HUC-HEART Trial). A Study Protocol of a Phase 1/2, Controlled and Randomized Trial in Combination with Coronary Artery Bypass Grafting |
| Q58726387 | Impact of Biomaterials on Differentiation and Reprogramming Approaches for the Generation of Functional Cardiomyocytes |
| Q36861491 | Increased potency of cardiac stem cells compared with bone marrow mesenchymal stem cells in cardiac repair |
| Q38041929 | Induced pluripotent stem cells for cardiac repair |
| Q37606016 | Innate Regeneration in the Aging Heart: Healing From Within |
| Q53599953 | Interleukin-6 contributes to the paracrine effects of cardiospheres cultured from human, murine and rat hearts |
| Q47236219 | Intracoronary Infusion of Allogeneic Mesenchymal Precursor Cells Directly After Experimental Acute Myocardial Infarction Reduces Infarct Size, Abrogates Adverse Remodeling, and Improves Cardiac Function |
| Q42137105 | Intracoronary Infusion of Autologous CD133(+) Cells in Myocardial Infarction and Tracing by Tc99m MIBI Scintigraphy of the Heart Areas Involved in Cell Homing |
| Q85708969 | Intracoronary infusion of encapsulated glucagon-like peptide-1-eluting mesenchymal stem cells preserves left ventricular function in a porcine model of acute myocardial infarction |
| Q38216863 | Iron, oxidative stress, and redox signaling in the cardiovascular system |
| Q33985922 | Local activation of cardiac stem cells for post‐myocardial infarction cardiac repair |
| Q36757779 | Long-Term Outcome of Administration of c-kit(POS) Cardiac Progenitor Cells After Acute Myocardial Infarction: Transplanted Cells Do not Become Cardiomyocytes, but Structural and Functional Improvement and Proliferation of Endogenous Cells Persist fo |
| Q30433102 | Low-intensity pulsed ultrasound induces angiogenesis and ameliorates left ventricular dysfunction in a porcine model of chronic myocardial ischemia |
| Q36791222 | Macrophage migration inhibitory factor promotes cardiac stem cell proliferation and endothelial differentiation through the activation of the PI3K/Akt/mTOR and AMPK pathways |
| Q53787304 | Mechanical Stress Regulates Endothelial Progenitor Cell Angiogenesis Through VEGF Receptor Endocytosis |
| Q38196627 | Mechanisms of exercise-induced cardiac growth |
| Q37285384 | Mechanisms of load dependency of myocardial ischemia reperfusion injury |
| Q35974359 | Mechanisms of myocardial regeneration |
| Q38073092 | Mesenchymal Stem Cells and Idiopathic Pulmonary Fibrosis. Potential for Clinical Testing |
| Q39297520 | Mesenchymal stem cell secreted platelet derived growth factor exerts a pro-migratory effect on resident Cardiac Atrial appendage Stem Cells |
| Q35597374 | MicroRNAs and Cardiac Regeneration |
| Q37998443 | MicroRNAs and stem cells: control of pluripotency, reprogramming, and lineage commitment |
| Q58996489 | MicroRNAs in Cardiovascular Regenerative Medicine: Directing Tissue Repair and Cellular Differentiation |
| Q48157567 | Monitoring of Cardiac Remodeling in a Mouse Model of Pressure-Overload Left Ventricular Hypertrophy with [(18)F]FDG MicroPET. |
| Q43225645 | Myocardial Isl(+)land: a place with lots of rhythm, but no beat |
| Q38045804 | Myocardial regeneration of the failing heart |
| Q38205363 | Myocyte renewal and therapeutic myocardial regeneration using various progenitor cells |
| Q52803732 | Novel Therapies Targeting Cardioprotection and Regeneration. |
| Q37990311 | Novel therapeutic approaches to post-infarction remodelling |
| Q36283312 | Nuclear Calcium/Calmodulin-dependent Protein Kinase II Signaling Enhances Cardiac Progenitor Cell Survival and Cardiac Lineage Commitment |
| Q27023325 | Origin of cardiomyocytes in the adult heart |
| Q35084744 | Oxytocin-Gly-Lys-Arg stimulates cardiomyogenesis by targeting cardiac side population cells |
| Q38136924 | Patching the heart: cardiac repair from within and outside |
| Q129411789 | Phase-contrast microtomography: are the tracers necessary for stem cell tracking in infarcted hearts? |
| Q46130031 | Pim1 Kinase Overexpression Enhances ckit+ Cardiac Stem Cell Cardiac Repair Following Myocardial Infarction in Swine |
| Q45230770 | Podocalyxin-like protein 1 is a relevant marker for human c-kit(pos) cardiac stem cells. |
| Q38132088 | Polymeric scaffold aided stem cell therapeutics for cardiac muscle repair and regeneration |
| Q37993142 | Potential for Stem Cell Use in Congenital Heart Disease |
| Q88219970 | Preclinical Studies of Stem Cell Therapy for Heart Disease |
| Q38048552 | Pro-angiogenic cell-based therapy for the treatment of ischemic cardiovascular diseases |
| Q36336441 | RETRACTED: Cardiomyogenesis in the aging and failing human heart |
| Q35975428 | REVIVE Trial: Retrograde Delivery of Autologous Bone Marrow in Patients With Heart Failure |
| Q38096037 | Recent Advancements in Tissue Engineering for Stem cell-based Cardiac Therapies |
| Q35669620 | Recent concepts for the roles of progenitor/stem cell niche in heart repair |
| Q33909634 | Recruitment and retention of human autologous CD34+ CD117+ CD133+ bone marrow stem cells to infarcted myocardium followed by directed vasculogenesis: Novel strategy for cardiac regeneration |
| Q36497191 | Regenerating new heart with stem cells |
| Q59795677 | Regenerating new heart with stem cells |
| Q38075698 | Regenerative medicine approach to repair the failing heart. |
| Q83302293 | Reprogrammed endothelial cells: cell therapy for coronary collateral growth? |
| Q26800082 | Reprogramming and transdifferentiation for cardiovascular development and regenerative medicine: where do we stand? |
| Q42870859 | Response to Bergmann et al: Carbon 14 Birth Dating of Human Cardiomyocytes |
| Q27300198 | Resveratrol treatment reduces cardiac progenitor cell dysfunction and prevents morpho-functional ventricular remodeling in type-1 diabetic rats |
| Q26744305 | Role of Telomerase in the Cardiovascular System |
| Q38443611 | Role of nitric oxide in the maintenance of pluripotency and regulation of the hypoxia response in stem cells. |
| Q30524835 | Secondary sphere formation enhances the functionality of cardiac progenitor cells |
| Q50894466 | Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 mutations in sporadic hypertrophic cardiomyopathy |
| Q48062283 | Stem Cell Therapies for Cardiovascular Diseases: What Does the Future Hold? |
| Q50075212 | Stem Cells in Regenerative Cardiology |
| Q38098219 | Stem cell stimulation of endogenous myocyte regeneration |
| Q34129904 | Stem cell therapy for cardiac dysfunction |
| Q38397750 | Stem cell therapy for chronic heart failure. |
| Q37991771 | Stem cells and regenerative medicine — future perspectives |
| Q58615556 | Stem cells as therapy for heart disease: iPSCs, ESCs, CSCs, and skeletal myoblasts |
| Q37940959 | Stem cells review series: an introduction |
| Q86583645 | Stimulation of Cardiomyocyte Regeneratory Reactions under Conditions of Cytopathic Hypercholesterolemia |
| Q37027716 | Sustained-Release Delivery of Prostacyclin Analogue Enhances Bone Marrow-Cell Recruitment and Yields Functional Benefits for Acute Myocardial Infarction in Mice |
| Q36912426 | Telomerase expression confers cardioprotection in the adult mouse heart after acute myocardial infarction |
| Q101559281 | Telomeres and telomerase in risk assessment of cardiovascular diseases |
| Q37325686 | The Potential of Stem Cells in the Treatment of Cardiovascular Diseases |
| Q38014348 | The Vascular Stem Cell Niche |
| Q37328786 | The advancing field of cell-based therapy: insights and lessons from clinical trials. |
| Q37625460 | The existence of myocardial repair: mechanistic insights and enhancements |
| Q38050284 | The heart's content-renewable resources. |
| Q38698411 | The influence of a spatiotemporal 3D environment on endothelial cell differentiation of human induced pluripotent stem cells |
| Q38116760 | The non-coding road towards cardiac regeneration. |
| Q38866803 | Therapeutic targeting of autophagy in myocardial infarction and heart failure. |
| Q36352412 | Tracking chromatid segregation to identify human cardiac stem cells that regenerate extensively the infarcted myocardium |
| Q38318626 | Trans-system mechanisms against ischemic myocardial injury |
| Q37254881 | Transcriptional profiling of HMGB1-induced myocardial repair identifies a key role for Notch signaling |
| Q38121727 | Vascular endothelial growth factor in heart failure |
| Q92312400 | [Epicardial Transplantation of Cardiac Progenitor Cells Based Cells Sheets is More Promising Method for Stimulation of Myocardial Regeneration, Than Conventional Cell Injections] |
| Q86055442 | [Stem cells for the treatment of cardiovascular diseases. An update] |
| Q38313140 | c-kit(+) cells: the tell-tale heart of cardiac regeneration? |
| Q46684066 | c-kit-Positive cardiac progenitor cells: the heart of stemness |
| Q36677020 | β-Adrenergic regulation of cardiac progenitor cell death versus survival and proliferation. |
Search more.